<DOC>
	<DOCNO>NCT00689026</DOCNO>
	<brief_summary>A large population-based study show diabetes independent risk factor colon cancer compare general population . Thus , completion adequately prepped colonoscopy requisite provide diabetic adequate colon cancer screening . Recent data show diabetic patient poorer response bowel cleanse compare non-diabetics ( standard PEG prep , 62 % diabetic patient colonoscopy prep rat good good vs. 97 % normal patient , p &lt; 0.001 ) . This may due fact majority diabetic patient report constipation common gastrointestinal complaint . We postulate lubiprostone ( Amitiza ) , combination PEG , additional efficacy standard PEG preparation , provide optimal safe effective colonic cleanse diabetic .</brief_summary>
	<brief_title>Efficacy Lubiprostone Combination With Standard PEG Preparation</brief_title>
	<detailed_description>STUDY DESIGN This investigator-initiated , single site ( MCG ) , single-blinded prospective study compare efficacy Lubiprostone 4L PEG ( Nulytely ) 4 Liters ( 4L ) PEG alone preparation quality patient know diabetes undergo colonoscopy . Diabetic outpatient require colonoscopy randomize one two group 60 ( total 120 patient ) : Control Group : All patient study receive standard oral 4L PEG colonoscopy preparation day prior schedule colonoscopy . Lubiprostone Group : The lubiprostone group receive additional two 24 mcg lubiprostone capsule , take orally morning even day 4L PEG prep ( oral 4L PEG preparation ) . Randomization Scheme : Subjects assign Control Group Lubiprostone Group , odd/even basis . After research inform consent obtain , subject give study Identification ( ID ) number 1 120 . Subjects odd number assign Control Group , subject even number assign Lubiprostone Group . Subjects give randomization package consist preparation order , supply , instruction date procedure investigator obtain informed consent . The colonoscopist blind preparation give . Only diabetic patient require outpatient colonoscopy gastroenterologist outpatient MCG Clinic eligible study . Patients presented separate consent form colonoscopy procedure . Standard Care Procedures - Colonoscopy Procedure Consent - Colonoscopy Study Procedures - Research Informed Consent - Disbursement randomize preparation order supply , instruction , date procedure subject - Adverse Events After procedure , physician perform colonoscopy complete form rate quality subject 's colonoscopy preparation 1-5 rating scale . The subject 's study participation duration two day ( day preparation day procedure ) . No follow-up visit occur .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Patients know diabetes ( type I II ) undergo elective colonoscopy Medical College Georgia . Patients age 50 year old . Women must postmenopausal surgically sterile . Patients able give valid , informed consent . Patients impair glucose tolerance . Patients suspect acute chronic pseudoobstruction . Patients active gastrointestinal bleeding . Patients known inflammatory bowel disease . Patients chronic diarrhea . Patients prior colonic resection . Patients active diverticulitis . Patients know colonic mass . Patients clinical evidence decompensated liver disease . Patients clinical evidence decompensated renal disease patient dialysis . Patients currently previously take lubiprostone . Patients allergy lubiprostone .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Colonoscopy</keyword>
	<keyword>Diabetes Mellitus , Type 1</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Cleansing</keyword>
	<keyword>Preparation</keyword>
	<keyword>PEG</keyword>
	<keyword>Quality</keyword>
</DOC>